Cypress Capital Group Raised Its Amazon.Com (AMZN) Position; Venbio Select Advisor Decreased Its Medicines Co (MDCO) Stake

November 14, 2017 - By Marie Mckinney

Cypress Capital Group increased Amazon.Com Inc (AMZN) stake by 334.45% reported in 2017Q2 SEC filing. Cypress Capital Group acquired 796 shares as Amazon.Com Inc (AMZN)’s stock rose 13.58%. The Cypress Capital Group holds 1,034 shares with $1.00M value, up from 238 last quarter. Amazon.Com Inc now has $547.56 billion valuation. The stock rose 0.63% or $7.14 reaching $1136.31 per share. About 1.61 million shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 37.41% since November 14, 2016 and is uptrending. It has outperformed by 20.71% the S&P500.

Venbio Select Advisor Llc decreased Medicines Co (MDCO) stake by 6.41% reported in 2017Q2 SEC filing. Venbio Select Advisor Llc sold 75,900 shares as Medicines Co (MDCO)’s stock declined 20.30%. The Venbio Select Advisor Llc holds 1.11 million shares with $42.16M value, down from 1.19 million last quarter. Medicines Co now has $2.27 billion valuation. The stock declined 0.80% or $0.25 reaching $31.11 per share. About 222,023 shares traded. The Medicines Company (NASDAQ:MDCO) has risen 16.70% since November 14, 2016 and is uptrending. It has by 0.00% the S&P500.

Venbio Select Advisor Llc increased Global Blood Therapeutics Inc stake by 45,000 shares to 860,000 valued at $23.52M in 2017Q2. It also upped Ascendis Pharma stake by 290,000 shares and now owns 990,924 shares. Array Biopharma Inc (NASDAQ:ARRY) was raised too.

Investors sentiment decreased to 1.22 in Q2 2017. Its down 0.19, from 1.41 in 2017Q1. It turned negative, as 34 investors sold MDCO shares while 51 reduced holdings. 29 funds opened positions while 75 raised stakes. 86.33 million shares or 0.70% less from 86.94 million shares in 2017Q1 were reported. Moreover, Ny State Common Retirement Fund has 0.01% invested in The Medicines Company (NASDAQ:MDCO) for 230,558 shares. Global X Management Communications Limited Liability Company, New York-based fund reported 472 shares. First Mercantile Co accumulated 4,767 shares. Tci Wealth reported 0% of its portfolio in The Medicines Company (NASDAQ:MDCO). Whittier Tru Of Nevada reported 991 shares. Putnam Investments Ltd reported 0.09% of its portfolio in The Medicines Company (NASDAQ:MDCO). Guggenheim Ltd Co reported 0.01% of its portfolio in The Medicines Company (NASDAQ:MDCO). Wells Fargo & Communications Mn invested in 105,300 shares. Mason Street Advsrs Limited Liability Corp owns 17,797 shares or 0.02% of their US portfolio. Fmr Limited Liability Corp reported 10.83 million shares stake. Proshare Advsr Limited Liability Co invested 0.02% of its portfolio in The Medicines Company (NASDAQ:MDCO). 2,750 were reported by Da Davidson. Atika Management reported 2.53% in The Medicines Company (NASDAQ:MDCO). Millennium Mngmt Lc has invested 0% in The Medicines Company (NASDAQ:MDCO). Voya Invest Mgmt reported 0% in The Medicines Company (NASDAQ:MDCO).

Among 10 analysts covering The Medicines Co (NASDAQ:MDCO), 8 have Buy rating, 0 Sell and 2 Hold. Therefore 80% are positive. The Medicines Co had 31 analyst reports since August 28, 2015 according to SRatingsIntel. Cowen & Co maintained the shares of MDCO in report on Wednesday, August 9 with “Buy” rating. The company was maintained on Wednesday, August 30 by Chardan Capital Markets. Chardan Capital Markets initiated The Medicines Company (NASDAQ:MDCO) rating on Wednesday, November 4. Chardan Capital Markets has “Buy” rating and $50 target. Citigroup maintained The Medicines Company (NASDAQ:MDCO) on Wednesday, July 26 with “Neutral” rating. The rating was upgraded by Jefferies on Friday, August 28 to “Hold”. As per Saturday, August 29, the company rating was maintained by JP Morgan. The rating was initiated by H.C. Wainwright with “Buy” on Monday, December 5. As per Monday, July 17, the company rating was maintained by Citigroup. Citigroup maintained the stock with “Neutral” rating in Monday, August 14 report. The rating was maintained by Cowen & Co on Tuesday, August 29 with “Buy”.

Analysts await The Medicines Company (NASDAQ:MDCO) to report earnings on February, 27. They expect $-1.63 EPS, down 26.36% or $0.34 from last year’s $-1.29 per share. After $-0.42 actual EPS reported by The Medicines Company for the previous quarter, Wall Street now forecasts 288.10% negative EPS growth.

Among 48 analysts covering Amazon.com (NASDAQ:AMZN), 45 have Buy rating, 0 Sell and 3 Hold. Therefore 94% are positive. Amazon.com had 232 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Amazon.com, Inc. (NASDAQ:AMZN) has “Buy” rating given on Friday, October 27 by SunTrust. Stifel Nicolaus maintained Amazon.com, Inc. (NASDAQ:AMZN) rating on Sunday, October 22. Stifel Nicolaus has “Buy” rating and $1100.0 target. The company was maintained on Friday, June 16 by Stifel Nicolaus. The stock of Amazon.com, Inc. (NASDAQ:AMZN) has “Neutral” rating given on Friday, July 29 by Suntrust Robinson. As per Tuesday, December 8, the company rating was initiated by Pacific Crest. The firm has “Buy” rating by UBS given on Friday, July 28. The firm has “Buy” rating given on Tuesday, September 1 by Oppenheimer. Citigroup maintained it with “Buy” rating and $780 target in Friday, April 29 report. The rating was maintained by Citigroup with “Buy” on Monday, November 28. Wedbush maintained the stock with “Outperform” rating in Friday, April 29 report.

Cypress Capital Group decreased Cvs Health Corp (NYSE:CVS) stake by 8,949 shares to 24,778 valued at $1.99M in 2017Q2. It also reduced Westrock Co stake by 10,496 shares and now owns 35,421 shares. Lockheed Martin Corp (NYSE:LMT) was reduced too.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>